Consensus Azitra, Inc.

Equities

AZTR

US05479L1044

Real-time Estimate Cboe BZX Other stock markets 12:09:43 2024-05-23 EDT			5-day change	1st Jan Change
0.2 ^USD	-0.10%		+0.86%	-78.26%

05-10	Azitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual Meeting	CI
05-09	Azitra, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Evolution of the average Target Price on Azitra, Inc.

Price target over the last 5 years

History of analyst recommendation changes

35a2d60a4206ce90e2fad36216d7ad.PQQpIQ1k__9c68e1K_8Q3CwVOSIIUMJWmrirI0Sjnpw.S2pobT1TyIkGjJffb4lKrFsnWhpLE7QAztT6bjzq8qp4YEttPTK2vgyfng~a28d6bd28a64961ab5dfac2b47235689